NDC 71904-300 – Opfolda
Miglustat 65 mg/1 · Capsule · Oral
Product NDC71904-300
Product details
- Brand name
- Opfolda
- Generic name
- Miglustat
- Labeler
- AMICUS THERAPEUTICS US, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA215211
- Marketed since
- October 11, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Enzyme Stabilizer; Glucosylceramide Synthase Inhibitor
Active ingredients
- Miglustat 65 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 71904-300-01 | 4 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-01) / 1 CAPSULE in 1 BOTTLE, PLASTIC | Oct 11, 2023 |
| 71904-300-02 | 24 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-02) / 1 CAPSULE in 1 BOTTLE, PLASTIC | Oct 11, 2023 |
| 71904-300-03 | 100 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-03) / 1 CAPSULE in 1 BOTTLE, PLASTIC | Oct 11, 2023 |